Peloton Therapeutics

Acquired

Peloton Therapeutics is a biotech company in United States, founded in 2010. It has raised $150.0M across 1 round, most recently a $150.0M Series E in February 2019.

United States | Cancer, HIF2-a

Founded
2010
Business Model
B2B
Total Funding
$150.0M
Last Round
$150.0M Series EFeb 2019
Rounds
1
Acquisition Date
May 2019

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 1 investor for this company. The full record is or through the API.

About

Peloton Therapeutics, Inc. is a clinical stage pharmaceutical company focused on translating novel scientific insights into first-in-class medicines for patients with cancer and other debilitating or life-threatening conditions. Peloton is initially targeting HIF-2α, a transcription factor which was previously thought to be intractable using a small molecule. The company is a leader in the field of HIF-2α biology and pioneered the first HIF-2α to enter into clinical development. Peloton has opportunities to completely transform established treatment paradigms and improve patient outcomes in kidney cancer, VHL Disease, and other serious diseases.

Summary

It has raised $150.0M in total across 1 round, most recently a $150.0M Series E round in Feb 2019. Investors include RA Capital Management.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
AcquisitionMay 2019

Sign up to see all 2 events

Funding: Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Peloton Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/peloton-therapeutics"><img src="https://indexed.vc/api/badge/company/peloton-therapeutics" alt="Peloton Therapeutics on Indexed.vc" width="260" height="76" /></a>